Trial
NCT06152042
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biomea Fusion Inc.
Collaborators
—
Condition
Type 1 Diabetes Mellitus
Intervention
BMF-219
Why stopped
Sponsor made a business decision to terminate the study based on prioritization of portfolio.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-14